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What’s known on the subject? and What does the study add?
• Detrusor underactivity is highly prevalent, particularly in the elderly. It is assumed to result from detrusor failure,
although detrusor contractility is often derived from urodynamics studies. Given that detrusor pressure and force are
not proportional and urodynamics cannot identify the basis of the pathology, we produced a neurogenic animal model
with a highly-compliant bladder and studied detrusor muscle properties, aiming to increase our understanding of the
underlying pathology.
• Highly compliant bladders were characterized by reduced passive wall stiﬀness and stretched detrusor muscle strips
exhibited an enhanced rate of relaxation. These detrusor strips displayed spontaneous contractions that were of greater
amplitude (expressed as a ratio of bladder wall stiﬀness) than those of strips from sham-operated animals; spontaneous
contractions increased in amplitude when stimulated by an agonist. These data imply that compliance is not the result
of a reduction of detrusor contractility; we hypothesize that altered matrix properties reduce the magnitude with which
force can be generated to void the bladder.
Objective
• To characterize passive and active changes in detrusor
activity in a highly compliant bladder.
Materials and Methods
• Bladders from adult female Sprague–Dawley rats were
used 5 weeks after lower thoracic (T8) spinal cord
transection or a sham-operation.
• Passive wall properties were assessed by pressure–volume
relationships from whole bladders and the tensile
response of bladder strips after a rapid (<0.5 s)
stretch.
• Active properties were assessed from the frequency and
amplitude of spontaneous contractions of bladder strips,
and their response to the inotropic TRPV4 agonist
GSK1016790A.
Results
• Passive bladder wall stiﬀness of SCT bladders was
signiﬁcantly reduced compared to that of the
sham-operated control group (N = 6 and 8, respectively)
and SCT bladder strips relaxed more quickly than those
from sham-operated rats.
• The frequency of spontaneous contractions was reduced
in SCT rats, and their amplitude, expressed as a ratio of
bladder wall stiﬀness, was greater than in sham-operated
rats.
• GSK1016790A (0.1 mM) signiﬁcantly increased amplitude
in strips from both sham-operated and SCT groups.
Conclusions
• There is no evidence of contractile failure in a
highly-compliant bladder. The observations of reduced
passive bladder wall stiﬀness and an enhanced rate of
stress relaxation lead to the conclusion that increased
compliance is marked by altered matrix properties that
dissipate muscle force, thereby generating low pressures.
• Contractile agonists may be eﬀective for improving
bladder function in detrusor underactivity.
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Introduction
Detrusor underactivity (DU) is a condition diagnosed
by pressure–ﬂow studies and is deﬁned as a bladder
contraction of either reduced strength and/or insuﬃcient
duration to complete voiding within a normal time-span
[1]. Often, but not exclusively, it occurs in elderly patients
and may be associated with overactive bladder symptoms
[2]. DU is regarded primarily as failure of detrusor
contractility, although this may require re-evaluation: DU
is associated more with a reduced rate of contraction
development rather than contractile strength, at least
initially [3]; cholinergic agonists are not eﬀective in
improving an underactive bladder [4,5] and there is no
evidence for age-related impairment of detrusor
contractility [6].
Urodynamic assessment of bladder contractility utilizes
procedures during voiding or when the bladder is
isovolumetric. Voiding measures include determination of
the Watts factor [7,8], a bladder contractility index [9] or
peak detrusor pressure measured at (or independent of)
peak ﬂow. Isovolumetric indices include the projected
isovolumetric pressure from pressure–ﬂow measurements
[10] and maximum pressure during outﬂow tract occlusion
[11]. Although informative, these methods are empirical
and their usefulness varies between diﬀerent patient groups
[10,12]. Furthermore, urodynamics cannot yield
fundamental information about the basis of DU (i.e. if it is
a true decline of muscle contractility or whether some
other factor is involved), which is compounded by the fact
that detrusor pressure is not proportional to true detrusor
force.
The present study aimed to develop a rat model of spinal
cord transection (SCT) to generate a highly compliant
bladder that develops low intraluminal pressures, aiming to
characterize any changes in detrusor contractility (i.e.
isometric force per unit cross-section of tissue). In a
complementary study [13], we showed that such bladders
developed smooth muscle hypertrophy, a loss of nerve
endings and signiﬁcant disruption of interstitial cell
number in both the detrusor and lamina propria layers.
The hypothesis that this was accompanied by reduced
muscle contractility was tested.
Materials and Methods
Experimental Groups
Adult female Sprague–Dawley rats were used 5 weeks
after SCT (animal weight 217–274 g) or a sham operation
(animal weight 252–292 g). In some experiments, an
unoperated group was also used (animal weight
260–300 g); all groups were age-matched. To produce
SCT, rats were anaesthetized with isoﬂurane (2% in O2,
0.6 L/min), a laminectomy was performed at T8 and the
spinal cord was sectioned with iris scissors. Complete
sectioning was conﬁrmed visually by slight retraction of
the two spinal cord segments. To assist rats with their
bladder voiding, a gentle abdominal compression was
performed twice daily until restoration of the micturition
reﬂex (ª2 weeks) and they were injected daily, for the ﬁrst
week after surgery, with gentamicin (2 mg/kg). Procedures
were carried out in accordance with the European
Community Council Directive 86/609/EEC. The sham
operation used the same procedure, although omitting the
laminectomy.
Some 5 weeks after the procedure, rats were weighed,
sacriﬁced by cervical dislocation and exsanguination, and
the urinary bladder was removed and weighed. Bladders
were transported in Ca-free Krebs solution (mM: NaCl
114, KCl 4.7, MgSO4 1.2, KH2PO4 1.2, NaHCO3 25,
glucose 11.7; 95% O2/5% CO2, pH 7.35) at 4 °C to the
laboratory.
Assessment of Wall Tension
Whole bladders were catheterized and ligated around the
urethra and bladder neck. Intravesical pressure and volume
were monitored at 10 Hz (Spike 2; Cambridge Electronic
Design, Cambridge, UK) and exported to Excel (Microsoft
Corp., Redmond, CA, USA) for analysis. Bladders were
ﬁlled (Minipuls3; Gilson, Middleton,WI, USA) at 12 mL/h
with Krebs until the pressure tended to a maximum or
where leakage around the catheter was observed.
Pressure–volume relationships were transformed into
tension-length (i.e. wall tension vs bladder circumference)
relationships, as described previously [14].
Isometric Tension Recording
In Ca2+-containing (2.5 mM CaCl2) Krebs solution, the
urinary bladder was opened longitudinally from the
bladder neck (posterior) to the top of the dome (anterior)
and the trigone was removed. The mucosa was also
removed from the remaining tissue by careful dissection
using iris scissors; care was taken not to stretch or damage
the underlying detrusor muscle. A single longitudinal strip
(ª5 ¥ 1 mm) was mounted in a 5-mL vertical organ bath
under a tension of 10 mN, and isometric spontaneous
contractions were measured. Preparations were
continuously washed with fresh, gassed Krebs and allowed
to equilibrate for 90 min before each experiment, with
resting tension maintained at 10 mN.When the resting
tension was stable, three sets of data were recorded: (i) a
5-min period of spontaneous contractions; (ii) the tensile
response after a rapid (<0.5 s) stretch to achieve an
immediate further increase of resting tension by 10 mN;
and (iii) upon relaxation of this additional tension, a
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15-min recording of spontaneous contractions in the
presence of a contractile agonist GSK1016790A (0.1 mM)
[15] or its vehicle, dimethyl-sulphoxide (0.1 mM). Data
were acquired using an in-house manufactured
analogue–digital converter attached to a computer running
Notocord-hem software, version 4.2 (Notocord,
Croissy-sur-Seine, France). At the end of each experiment,
the wet weight (W) and length (l) of each strip were
recorded to estimate cross-sectional area (CSA) using the
formula: CSA = W/lr, where r is the density of tissue
(1.05 g/cm3).
Analysis of Isometric Contraction Traces
To analyze spontaneous contraction amplitude and basal
tone, data were imported into Chart, version 5.5
(ADInstruments, Chalgrove, UK) at 10 Hz and values were
derived using a custom-written macro. Spontaneous
contraction amplitude was the baseline-to-peak amplitude,
and the baseline was the minimum isometric tension value,
obtained as the mean over a 5-min period. The frequency
of spontaneous contractions was calculated using
custom-written software (R. J. Young, Department of
Physics, University of Lancaster, UK) by ﬁrst performing a
fast-Fourier transform on the data and then identifying the
dominant frequency (f0) based on a Lorentzian ﬁt to an
amplitude vs frequency plot. Frequency values were not
reported when the level of activity was so infrequent, or its
frequency so variable, that a frequency proﬁle could not
accurately be described. Contraction data were integrated
using Kaleidagraph, version 3.5 (Synergy Software, Reading,
PA, USA) for 5-min period before and after intervention.
The baseline was taken as mean of the 100 lowest values for
each of these periods.
Statistical Analysis
Many data sets were not normally distributed and/or had
diﬀerent variances, as tested by Kolmogorov–Smirnov and
Levene’s tests, respectively. Data are therefore presented as
median values with 25% (Q1) and 75% (Q3) interquartiles.
Values from the sham-operated group are provided ﬁrst.
Diﬀerences between data sets were examined by a
Wilcoxon rank test for two data sets or a Kruskal–Wallis
test for multiple sets. P < 0.05 was considered statistically
signiﬁcant. The variability of data within a given set was
quantiﬁed by calculation of the coeﬃcient of quartile
deviation (Q3 - Q1)/(Q3 + Q1). N refers to the number of
rats. Rates of relaxation for detrusor strips were calculated
over a 2.5-min period after retensioning (to 10 mN) using a
single-order exponential decay ﬁt with a non-zero
asymptote (GraphPad Prism, version 4; GraphPad Software
Inc., San Diego, CA, USA) and noting the decay constant,
k (s–1).
Results
Ex Vivo Bladder Stress-Strain Properties
The passive wall tension–length relationship obtained
from ex vivo ﬁlling pressure–volume curves showed that
bladders from SCT rats were less stiﬀ than those from
sham-operated rats.Wall tension (T) vs bladder
circumference (l) curves (Fig. 1) were biphasic; the initial
phase, characterized by a shallow slope, corresponded to
ﬁlling of the bladder when the wall was under minimal
tension. Once the bladder had ﬁlled and was more or less
spherical, the T/l relationship was linear. The slope of this
linear phase was used to estimate passive bladder wall
stiﬀness, DT/Dl. The mean (range) stiﬀness of SCT
bladders was signiﬁcantly less compared to that of the
sham-operated control group: 5.60 (2.81–7.70) vs 1.61
(0.92–2.04) mN/mm2 (N = 6 and 8, respectively). As a
result of the reduction in wall stiﬀness, SCT animal
bladders were classiﬁed as highly-compliant.
Spontaneous Contractile Activity
Bladder strips from sham-operated and SCT rats generated
spontaneous contractions (Fig. 2A). These were
characterized to determine whether tissue from
highly-compliant bladders had a phenotype of
long-duration, fused contractions as a result of SCT [16]. A
Fast-Fourier transform of tension-time data identiﬁed the
dominant frequency (f0) of spontaneous contractions based
Fig. 1 Ex vivo wall tension (T) vs bladder circumference (l) curves from
sham-operated or spinal-cord transected (SCT) rats.
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on a Lorentzian ﬁt (Fig. 2B). The mean (range) frequency
was signiﬁcantly reduced in detrusor strips from SCT
compared to sham-operated rats: 0.113 (0.084–0.142) vs
0.051 (0.038–0.068) Hz (N = 18 and 18, respectively) (P <
0.001). The mean (range) amplitude of spontaneous
contractions was not diﬀerent between those from SCT and
sham-operated rats: 4.8 (2.3–6.5) vs 2.1 (1.7–3.4) mN/mm2
(N = 18 and 18, respectively) (Fig. 3A). Although the SCT
median value was less than for the sham-operated group, it
did not reach statistical signiﬁcance. In addition, the
variability of amplitudes was not diﬀerent between the two
groups, as indicated by the mean (range) coeﬃcient of
quartile deviation: 0.96 (0.53–1.37) vs 0.47 (0.27–0.65).
The reduced passive stiﬀness of SCT bladder strips will
reduce the magnitude of a recorded isometric contraction
for the same contractile eﬀort made by detrusor muscle.
This is because the force developed by the muscle would be
dissipated by the less stiﬀ passive mechanical properties of
the tissue. To correct for this eﬀect, the amplitudes of
spontaneous contractions (mN/mm2) were expressed as a
ratio of bladder wall stiﬀness (mN/mm2) from which the
strip was dissected, yielding a dimensionless value of
tension independent of wall stiﬀness (Fig. 3B).With this
transformation, the mean (range) amplitude of spontaneous
contractions was signiﬁcantly greater in SCT rats compared
to sham-operated rats: 1.31 (0.97–2.85) vs 0.86 (0.38–1.05)
mN/mm2 (P < 0.001).
Passive Stress–Relaxation Properties
Detrusor strips were rapidly stretched to increase resting
tension by a further 10 mN and then allowed to relax.
Figure 4A shows the decay of resting tension with
superimposed spontaneous contractions. Strips from SCT
rats relaxed signiﬁcantly more quickly than those from
sham-operated rats; the mean (range) decay constants, k,
were 0.0034 (0.0031–0.0061) vs 0.010 (0.0081–0.020)/s (N =
17 and 18, respectively); the asymptotic values were not
diﬀerent in the two groups (median of 47% and 43%,
respectively).
Control Experiments
Data from detrusor strips of an unoperated animal group
were also collected to determine whether surgery itself
altered the contractile phenotype and, accordingly, were
compared with those from the sham-operated group. The
Fig. 2 Spontaneous contractions in detrusor strips from
sham-operated and spinal-cord transected (SCT) rats. A, Spontaneous
contraction recordings. B, Fourier transforms of the data showing the
occurrence (power) of contractions at different frequencies, with
dominant frequency (f0) indicated by arrows.
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Fig. 3 Magnitude of spontaneous contractions in detrusor strips from
sham-operated or spinal-cord transected (SCT) rats. A, Absolute
tension values. B, Values normalized to passive stiffness. Median
values (25%, 75% interquartiles). *P < 0.05 Wilcoxon rank test vs
sham-operated values.
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spontaneous contraction dominant frequency,
f0 (0.085 [0.077–0.103] Hz, N = 24), amplitude (3.2
[2.2–5.9] mN/mg) and decay constant, k (0.40
[0.34–0.055] min–1, N = 18) were not signiﬁcantly diﬀerent
from sham-operated values and, in the case of f0 and k
values, they were diﬀerent from the SCT group.
Response to a Detrusor-Selective
Contractile Agonist
GSK1016790A (0.1 mM), a potent detrusor-selective
contractile agonist [15], was tested on baseline tension and
the amplitude of spontaneous contractile activity in
sham-operated (Fig. 5A) and SCT detrusor strips (Fig. 5B).
The eﬀect of vehicle alone is also shown. Figure 5C
summarizes the eﬀect of GSK1016790A on contraction
amplitude and shows that vehicle had no eﬀect, although
the drug signiﬁcantly increased the amplitude in strips
from both sham-operated and SCT groups. The percentage
increase in the two groups was not signiﬁcantly diﬀerent.
Discussion
Detrusor underactivity is a prevalent condition that is
estimated to occur in almost two-thirds of elderly
incontinent nursing home patients [17]. Existing
pharmacotherapy is ineﬀective, with symptoms being
reported to worsen after anti-cholinergic therapy [4,5]. The
condition is often misdiagnosed in men as bladder outlet
obstruction [4,18], such that a-adrenoceptor antagonists
may also worsen symptoms. To direct the development of
eﬀective therapies, it is important to determine whether
detrusor underactivity is primarily a problem of contractile
failure or an alternative aetiology.
Highly-compliant bladders were generated by leaving
rats for 5 weeks after lower thoracic (T8) SCT. At earlier
times before surgery (ª2 weeks), the bladder is already
hypertrophied but has not developed a hypercompliant
phenotype observed after the longer interval in these
experiments [16,19]. The principal objective was to
determine whether the reduced intravesical pressures were
accompanied by reduced detrusor contractility or were the
result of another cause. A parallel study [13] recording the
morphological features of these bladders showed signiﬁcant
denervation, which is characteristic of detrusor
underactivity [4,20,21], as well as a loss of interstitial
cells between muscle bundles. An ex vivo preparation
circumvented the possible impact of altered sensory
function [22]; how this contributes to detrusor
underactivity in vivo warrants further investigation.
Contractile Performance of SCT Detrusor Muscle
Detrusor strips exhibited spontaneous contractions of
greater duration and lower frequency in SCT rats and were
characteristic of those recorded in overactive bladder
models [18]. However, their amplitude was not signiﬁcantly
diﬀerent from those recorded in control strips.When the
magnitude of the contraction was normalized to unit
passive ex vivo stiﬀness, the magnitude of contractions
was greater in the SCT group. The rationale for this
normalization is that the tension generated by detrusor
smooth muscle cells is transmitted through the extracellular
matrix before being recorded by the force transducer. Thus,
Fig. 4 Stress–relaxation of detrusor strips from sham-operated or
spinal-cord transected (SCT) rats. A, Traces of spontaneous
contractions and relaxation of baseline tension. B, Values of rate
constants of baseline relaxation. Median values (25%, 75%
interquartiles). *P < 0.05 Wilcoxon rank test vs sham-operated values.
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Fig. 5 The effect of GSK101670A (0.1 μM) on spontaneous
contractions in detrusor strips from sham-operated or spinal-cord
transected (SCT) rats. A, Recordings in vehicle or GSK101670A from
sham-operated bladders. B, Recordings from SCT bladders.C,
Summary of spontaneous contraction amplitude in vehicle or
GSK101670A (pre-exposure = 100%). Median values (25%, 75%
interquartiles). *P < 0.05 Wilcoxon rank test GSK101670A vs vehicle.
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dissipation of muscular energy through a more compliant
extracellular matrix will reduce the measured tension.
A signiﬁcant rate of passive stress relaxation will also
reduce the measured peak contractile force by acting as a
viscous damper. An increased rate was measured in
detrusor strips from SCT rats and would be expected to
have a greater inﬂuence on these strips. A quantitative
relationship has been described previously [23] and, using
the above rate constants, would reduce the peak force of
spontaneous contractions by ª2% in the control strips and
by 10% in the SCT strips: thus, the active contractile force
would be underestimated to a greater extent in SCT strips.
One test of contractility comprised the use of an inotropic
agent targeted to detrusor muscle, namely the TRPV4
agonist GSK1016790A; however, similar observations were
made with the muscarinic agonist carbachol. GSK1016790A
evoked muscle contracture and a similar increase in the
amplitude of spontaneous contractions in detrusor from
both control and SCT bladders without altering their
frequency. Given a signiﬁcant reduction in interstitial
cells in the SCT bladder wall [13], these data imply
that spontaneous activity is not entirely interstitial
cell-generated.
Overall, there is no evidence of contractile failure in the
highly-compliant bladder and it is proposed that increased
compliance is marked by altered matrix properties that
dissipate muscle force to produce a compliant bladder that
generates low pressures.
Alterations to Extracellular Matrix in
Bladder Hypertrophy
Hypertrophy is associated with increased collagen
deposition, at least in the early stages, as well as a decrease
in the type I to type III ratio [24,25]. Collagen subtype
changes may lead to changes in the passive mechanical
properties described above because a decrease in the type
I/III ratio is associated with reduced bladder compliance
[25]. Conversely, the tendency of collagen III to form large
coils may allow the bladder to hold large volumes more
readily [26]. Altered collagen deposition and subtype
composition are controlled by growth factors [27,28],
whose own release is up-regulated in the hypertrophic
bladder [29]. Further studies are required to measure the
changes in collagen distribution and subtype composition
in the underactive bladder.
In conclusion, a model of detrusor underactivity associated
with low bladder compliance was generated using spinal
cord-transected rats. There was no evidence of impaired
detrusor contractility and an overactive phenotype.
However, reduced passive bladder wall stiﬀness and an
enhanced rate of stress relaxation lead to the conclusion
that changes to the tissue matrix will result in a
low-pressure bladder. This implies that contractile agonists
may be eﬀective for improving bladder function and that
long-term correction may be achieved by reversing the
changes to passive bladder wall mechanical function.
Acknowledgements
John S. Young is funded by an AgeUK Research Fellowship.
This work was funded by an EU FP7 grant ‘INComb’
(http://www.incomb.eu). The authors thank Dr R. J. Young
(Department of Physics, University of Lancaster, UK) for
development of the software analysing the frequency of
spontaneous contractions.
Conflict of Interest
Gordon McMurray is an Employee of Pﬁzer and
Christopher H. Fry is on the Advisory Board of Eli Lilly.
References
1 Abrams P, Cardozo L, Fall M et al. The
standardisation of terminology of lower urinary tract
function: report from the Standardisation
Sub-committee of the International Continence
Society. Neurourol Urodyn 2002; 21: 167–78
2 Resnick NM, Yalla SV. Detrusor hyperactivity with
impaired contractile function. an unrecognized but
common cause of incontinence in elderly patients.
JAMA 1987; 257: 3076–81
3 Cucchi A, Quaglini S, Rovereto B. Proposal for a
urodynamic redeﬁnition of detrusor underactivity.
J Urol 2009; 181: 225–9
4 Taylor JA, Kuchel GA. Detrusor underactivity: clinical
features and pathogenesis of an underdiagnosed
geriatric condition. J Am Geriatr Soc 2006; 54: 1920–32
5 Krishnamoorthy S, Kekre NS. Detrusor underactivity:
to tone or not to tone the bladder? Indian J Urol 2009;
25: 407–8
6 Fry CH, Bayliss M, Young JS, Hussain M. Inﬂuence
of age and bladder dysfunction on the contractile
properties of isolated human detrusor smooth muscle.
BJU Int 2011; 108: E91–6
7 Griﬃths DJ, van Mastrigt R. The routine assessment
of detrusor contraction strength. Neurourol Urodyn
1985; 4: 77–87
8 Griﬃths DJ. Assessment of detrusor contraction
strength or contractility. Neurourol Urodyn 1991; 10:
1–18
9 Schäfer W. Analysis of bladder outlet function with the
linearised passive urethral resistance relation, linPURR,
and a disease-speciﬁc approach for grading
obstruction: from complex to simple.World J Urol
1995; 13: 47–58
Young et al.
360 © 2012 BJU International
10 Griﬃths DJ. Detrusor contractility: order out of chaos.
Scand J Urol Nephrol 2004; 215 (Suppl): 93–100
11 Sullivan MP, Yalla SV, DuBeau C, Cravalho EG.
Continuous outlet occlusion test to determine detrusor
contractile performance. J Urol 1995; 154: 1834–40
12 Tan TL, Bergmann MA, Griﬃths D, Resnick NM.
Stop test or pressure–ﬂow study? Measuring detrusor
contractility in older females. Neurourol Urodyn 2004;
23: 184–9
13 Johnston L, Cunningham RM, Young JS et al. Altered
distribution of interstitial cells and innervation in
the rat urinary bladder following spinal cord injury.
J Cell Mol Med 2011; [Epub ahead of print]
doi: 10.1111/j.1582-4934.2011.01410.x
14 Thiruchelvam N, Wu C, David A, Woolf AS, Cuckow
PM, Fry CH. Neurotransmission and viscoelasticity in
the ovine fetal bladder after in utero bladder outﬂow
obstruction. Am J Physiol 2003; 284: R1296–305
15 Thorneloe KS, Sulpizio AC, Lin Z et al. N-((1S)-
1-{[4-((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino}-
3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-
methylbutyl)-1-benzothiophene-2-carboxamide
(GSK1016790A), a novel and potent transient receptor
potential vanilloid 4 channel agonist induces urinary
bladder contraction and hyperactivity: part I.
J Pharmacol Exp Ther 2008; 326: 432–42
16 Ikeda Y, Kanai A. Urotheliogenic modulation of
intrinsic activity in spinal cord-transected rat bladders:
role of mucosal muscarinic receptors. Am J Physiol
2008; 295: F454–61
17 Resnick NM, Yalla SV, Laurino E. The
pathophysiology of urinary incontinence among
institutionalized elderly persons. N Engl J Med 1989;
320: 1–7
18 Smith PP. Aging and the underactive detrusor: a
failure of activity or activation? Neurourol Urodyn
2010; 29: 408–12
19 Pikov V, Wrathall JR. Altered glutamate receptor
function during recovery of bladder detrusor-external
urethral sphincter coordination in a rat model of spinal
cord injury. J Pharmacol Exp Ther 2002; 300: 421–7
20 German K, Bedwani J, Davies J, Brading AF,
Stephenson TP. Physiological and morphometric
studies into the pathophysiology of detrusor
hyperreﬂexia in neuropathic patients. J Urol 1995; 153:
1678–83
21 Drake MJ, Hedlund P, Mills IW et al. Structural and
functional denervation of human detrusor after spinal
cord injury. Lab Invest 2000; 80: 1491–9
22 Steers WD, Mackway Gerardi AM, Ciambotti J, de
Groat WC. Alterations in neural pathways to the
urinary bladder of the rat in response to STZ-induced
diabetes. J Auton Nerv Syst 1994; 47: 83–94
23 Wyndaele JJ, Gammie A, Bruschini H et al. Bladder
compliance what does it represent: can we measure it,
and is it clinically relevant? Neurourol Urodyn 2011; 30:
714–22
24 Kim JC, Yoon JY, Seo SI, Hwang TK, Park YH. Eﬀects
of partial bladder outlet obstruction and its relief on
types I and III collagen and detrusor contractility in
the rat. Neurourol Urodyn 2000; 19: 29–42
25 Deveaud CM, Macarak EJ, Kucich U, Ewalt DH,
Abrams WR, Howard PS. Molecular analysis of
collagens in bladder ﬁbrosis. J Urol 1998; 160: 1518–27
26 Chang SL, Howard PS, Koo HP, Macarak EJ. Role of
type III collagen in bladder ﬁlling. Neurourol Urodyn
1998; 17: 135–45
27 Imamura M, Kanematsu A, Yamamoto S et al. Basic
ﬁbroblast growth factor modulates proliferation and
collagen expression in urinary bladder smooth muscle
cells. Am J Physiol 2007; 293: F1007–17
28 Chung CW, Zhang QL, Qiao LY. Endogenous nerve
growth factor regulates collagen expression and bladder
hypertrophy through Akt and MAPK pathways during
cystitis. J Biol Chem 2010; 285: 4206–12
29 Yamaguchi O. Response of bladder smooth muscle
cells to obstruction: signal transduction and the role of
mechanosensors. Urology 2004; 63 (Suppl 1): 11–6
Correspondence: Christopher H. Fry, Institute of
Biosciences and Medicine, University of Surrey, Guildford
GU2 7XH, UK.
e-mail: c.h.fry@surrey.ac.uk
Abbreviations: DU, detrusor underactivity; SCT, spinal cord
transection.
The neurogenic, underactive bladder
© 2012 BJU International 361
